Additional Information
Book Details
Abstract
There is a difference in drug handbooks. And if you want the most reliable information presented in FULL color and organized alphabetically, Mosby’s Nursing Drug Reference is the only one that should be in your consideration set! With an A to Z organization, no other drug handbook helps you access reliable drug information quicker. But perhaps best of all, this full-color handbook gives you extensive drug information for over 5,000 generic and trade-name drugs — including uses, side effects, interactions, and pharmacokinetics. This reference also includes key nursing considerations to help you assess, administer, evaluate, and teach your patients, as well as instructions for giving drugs by various routes (e.g., PO, IM, IV). Written by a well-known expert in nursing pharmacology, you will ALWAYS find the latest and most trustworthy drug information in Mosby’s Nursing Drug Reference.
- 4-color design helps users easily and quickly find key information.
- This e-book allows users to quickly find important information with custom navigation. Search and find drugs by Generic and Trade names. Also included is a linked, comprehensive list of all drugs found in the book.
- Linked index allows users to click on a link and go straight to monographs quickly.
- With this e-book, users can access drug information on nearly any mobile device!
- Comprehensive and easy to find drug information.
- Comprehensive drug monographs contain the latest information on:
- Rx or OTC designations
- generic names
- pronunciations
- U.S. and Canadian trade names
- functional and chemical classification
- controlled-substance schedule
- do-not-confuse drugs
- actions, uses, unlabeled uses, dosages and routes
- available forms
- side effects
- contraindications
- precautions
- pharmacokinetics
- interactions (including drug/herb, drug/food and drug lab test)
- nursing considerations
- treatment of overdose
- Nursing Process steps used as the framework for organizing all information.
- Alphabetical listing of drug monographs by generic drug name.
- Emphasis on safety and safe drug administration.
- Black Box Warnings alert to dangerous and/or life-threatening adverse effects.
- Safety Alert icons call out the most critical interactions and side-effects that nurses must watch for.
- IV drug information, including special considerations and Y-site, syringe, and additive compatibilities.
- Common and life-threatening side effects are organized by body system for easy identification.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front cover | Cover | ||
Evolve learning system | ifc3 | ||
Front matter | i | ||
Copyright | iv | ||
Consultants | v | ||
Preface | vii | ||
New features | vii | ||
New facts | vii | ||
Organization | vii | ||
Individual drug monographs | vii | ||
Appendixes | viii | ||
Table of contents | xi | ||
How to use | ifc1 | ||
Drug categories | 1 | ||
α-adrenergic blockers | 1 | ||
A | 55 | ||
Abacavir (Rx) | 56 | ||
Abatacept (Rx) | 56 | ||
Abciximab (Rx) | 58 | ||
Abiraterone | 58 | ||
Acarbose (Rx) | 58 | ||
Acebutolol (Rx) | 60 | ||
Acetaminophen (OTC) | 62 | ||
Acetazolamide (Rx) | 64 | ||
Acetylcholine ophthalmic | 66 | ||
Acetylcysteine (Rx) | 66 | ||
Acyclovir (Rx) | 68 | ||
Acyclovir topical | 71 | ||
Adalimumab (Rx) | 71 | ||
Adefovir (Rx) | 73 | ||
Adenosine (Rx) | 74 | ||
Aflibercept | 75 | ||
Albumin, human 5%/25% (Rx) | 75 | ||
Albuterol (Rx) | 77 | ||
Aldesleukin, IL-2 (Rx) | 79 | ||
Alemtuzumab (Rx) | 81 | ||
Alendronate (Rx) | 83 | ||
Alfuzosin (Rx) | 84 | ||
Aliskiren (Rx) | 85 | ||
Allopurinol (Rx) | 87 | ||
Almotriptan (Rx) | 89 | ||
Alprazolam (Rx) | 90 | ||
Controlled substance schedule IV | 90 | ||
Action: | 90 | ||
Uses: | 90 | ||
Contraindications: | 90 | ||
Precautions: | 90 | ||
Dosage and routes | 90 | ||
Side effects | 91 | ||
Pharmacokinetics | 91 | ||
Interactions | 91 | ||
Nursing considerations | 91 | ||
Treatment of overdose: | 92 | ||
Alprostadil (Rx) | 92 | ||
Alteplase (tissue plasminogen activator, t-PA) (Rx) | 92 | ||
Aluminum hydroxide (OTC) | 95 | ||
Amantadine (Rx) | 96 | ||
Ambrisentan (Rx) | 97 | ||
Amifostine (Rx) | 99 | ||
Amikacin (Rx) | 101 | ||
Amiloride (Rx) | 104 | ||
Amino acid injection (Rx) | 105 | ||
Amino acid solution (Rx) | 106 | ||
Aminophylline (theophylline ethylenediamine) (Rx) | 107 | ||
Amiodarone (Rx) | 110 | ||
Amitriptyline (Rx) | 112 | ||
Amlodipine (Rx) | 114 | ||
Amoxicillin (Rx) | 116 | ||
Amoxicillin/clavulanate (Rx) | 118 | ||
Amphotericin B lipid based (Rx) | 120 | ||
Amphotericin B liposomal (Rx) | 120 | ||
Ampicillin (Rx) | 122 | ||
Ampicillin, sulbactam (Rx) | 125 | ||
Anagrelide (Rx) | 127 | ||
Anakinra (Rx) | 128 | ||
Anastrozole (Rx) | 129 | ||
Anidulafungin (Rx) | 130 | ||
Antihemophilic factor VIII (AHF) (Rx) | 133 | ||
Antithrombin III, human (Rx) | 134 | ||
Antithymocyte | 135 | ||
Apraclonidine ophthalmic | 135 | ||
Aprepitant (Rx) | 135 | ||
Fosaprepitant | 135 | ||
Arformoterol (Rx) | 137 | ||
Argatroban (Rx) | 138 | ||
Aripiprazole (Rx) | 140 | ||
Armodafinil (Rx) | 142 | ||
Controlled substance schedule IV | 142 | ||
Uses: | 142 | ||
Contraindications: | 142 | ||
Dosage and routes | 142 | ||
Ascorbic acid (vit C) (OTC, Rx) | 142 | ||
Asenapine (Rx) | 143 | ||
Asparaginase erwinia chrysanthemi | 145 | ||
Asparaginase (Rx) | 145 | ||
Aspirin (OTC) | 145 | ||
Atazanavir (Rx) | 148 | ||
Atenolol (Rx) | 150 | ||
Atomoxetine (Rx) | 152 | ||
Atorvastatin (Rx) | 153 | ||
Atovaquone (Rx) | 154 | ||
Atracurium (Rx) | 155 | ||
Atropine (Rx) | 156 | ||
Atropine ophthalmic | 157 | ||
Auranofin (Rx) | 158 | ||
Axitinib | 158 | ||
Azacitidine (Rx) | 158 | ||
Azathioprine (Rx) | 159 | ||
Azelaic acid topical | 161 | ||
Azelastine nasal agent | 161 | ||
Azelastine ophthalmic | 161 | ||
Azilsartan | 161 | ||
Azithromycin (Rx) | 161 | ||
Azithromycin ophthalmic | 164 | ||
Aztreonam (Rx) | 164 | ||
B | 164 | ||
Bacitracin topical | 164 | ||
Baclofen (Rx) | 164 | ||
Balsalazide (Rx) | 166 | ||
Basiliximab (Rx) | 167 | ||
Beclomethasone (Rx) | 168 | ||
Beclomethasone nasal agent | 169 | ||
Belatacept | 169 | ||
Belimumab | 171 | ||
Benazepril (Rx) | 173 | ||
Bendamustine (Rx) | 174 | ||
Benzocaine topical | 176 | ||
Benzonatate (Rx) | 176 | ||
Benztropine (Rx) | 176 | ||
Beractant (Rx) | 178 | ||
Betamethasone (Rx) | 178 | ||
Betamethasone topical | 180 | ||
Betamethasone (augmented) topical | 180 | ||
Betaxolol ophthalmic | 180 | ||
Bethanechol (Rx) | 180 | ||
Bevacizumab (Rx) | 181 | ||
Bicalutamide (Rx) | 183 | ||
Bimatoprost ophthalmic | 184 | ||
Bisacodyl (Rx, OTC) | 184 | ||
Bismuth subsalicylate (OTC) | 185 | ||
Bisoprolol (Rx) | 186 | ||
Bivalirudin (Rx) | 188 | ||
Bleomycin (Rx) | 190 | ||
Boceprevir | 193 | ||
Boric acid otic | 196 | ||
Bortezomib (Rx) | 196 | ||
Bosentan (Rx) | 197 | ||
Brentuximab | 198 | ||
Brimonidine ophthalmic | 200 | ||
Brinzolamide ophthalmic | 200 | ||
Bromfenac ophthalmic | 200 | ||
Bromocriptine (Rx) | 200 | ||
Brompheniramine (Rx) | 202 | ||
Budesonide (Rx) | 203 | ||
Budesonide nasal agent | 204 | ||
Bumetanide (Rx) | 204 | ||
Buprenorphine (Rx) | 207 | ||
Controlled substance schedule V (parenteral); schedule III (tablet, TD) | 207 | ||
Action: | 207 | ||
Uses: | 207 | ||
Contraindications: | 207 | ||
Precautions: | 207 | ||
Dosage and routes | 207 | ||
Side effects | 208 | ||
Pharmacokinetics | 209 | ||
Interactions | 209 | ||
Nursing considerations | 209 | ||
Treatment of overdose: | 209 | ||
Bupropion (Rx) | 209 | ||
Buspirone (Rx) | 211 | ||
Busulfan (Rx) | 213 | ||
Butoconazole vaginal antifungal | 215 | ||
Butorphanol (Rx) | 215 | ||
Controlled substance schedule IV | 215 | ||
Action: | 215 | ||
Uses: | 215 | ||
Contraindications: | 215 | ||
Precautions: | 215 | ||
Dosage and routes | 216 | ||
Side effects | 217 | ||
Pharmacokinetics | 217 | ||
Interactions | 217 | ||
Nursing considerations | 217 | ||
Treatment of overdose: | 217 | ||
C | 218 | ||
Cabazitaxel | 218 | ||
Calcitonin (rDNA) (Rx) | 220 | ||
Calcitonin (salmon) (Rx) | 220 | ||
Calcitriol vitamin D3 (Rx) | 221 | ||
Calcium carbonate (PO-OTC) | 223 | ||
Calcium acetate (OTC) | 223 | ||
Calcium chloride (Rx) | 225 | ||
Calcium gluceptate (Rx) | 225 | ||
Calcium gluconate (Rx) | 225 | ||
Calcium lactate (Rx) | 225 | ||
Calfactant (Rx) | 227 | ||
Candesartan (Rx) | 227 | ||
Capecitabine (Rx) | 228 | ||
Captopril (Rx) | 231 | ||
Carbachol ophthalmic | 233 | ||
Carbamazepine (Rx) | 233 | ||
Carbidopa-levodopa (Rx) | 235 | ||
Carboplatin (Rx) | 237 | ||
Carboprost (Rx) | 240 | ||
Carisoprodol (Rx) | 240 | ||
Carmustine (Rx) | 242 | ||
Carteolol ophthalmic | 243 | ||
Carvedilol (Rx) | 244 | ||
Caspofungin (Rx) | 245 | ||
Cefaclor | 247 | ||
Cefadroxil | 247 | ||
Cefazolin | 247 | ||
Cefdinir | 247 | ||
Cefditoren pivoxil | 247 | ||
Cefepime | 247 | ||
Cefixime | 247 | ||
Cefotaxime | 247 | ||
Cefotetan | 247 | ||
Cefoxitin | 247 | ||
Cefpodoxime | 247 | ||
Cefprozil | 247 | ||
Ceftazidime | 247 | ||
Ceftibuten | 247 | ||
Ceftizoxime | 247 | ||
Ceftriaxone | 247 | ||
Cefuroxime | 247 | ||
Ceftaroline (Rx) | 248 | ||
Celecoxib (Rx) | 249 | ||
Cephalexin | 250 | ||
Cefadroxil (Rx) | 251 | ||
Cefazolin (Rx) | 251 | ||
Cephalexin (Rx) | 251 | ||
Cefaclor (Rx) | 254 | ||
Cefotetan (Rx) | 254 | ||
Cefoxitin (Rx) | 254 | ||
Cefprozil (Rx) | 254 | ||
Cefuroxime (Rx) | 254 | ||
Cefdinir (Rx) | 258 | ||
Cefditoren pivoxil (Rx) | 258 | ||
Cefepime (Rx) | 258 | ||
Cefixime (Rx) | 258 | ||
Cefotaxime (Rx) | 258 | ||
Cefpodoxime (Rx) | 258 | ||
Ceftazidime (Rx) | 258 | ||
Ceftibuten (Rx) | 258 | ||
Ceftizoxime (Rx) | 258 | ||
Ceftriaxone (Rx) | 258 | ||
Cephradine | 266 | ||
Certolizumab pegol (Rx) | 266 | ||
Cetirizine (Rx, OTC) | 268 | ||
Cetrorelix (Rx) | 269 | ||
Cetuximab (Rx) | 270 | ||
Charcoal, activated (oTC) | 272 | ||
Chloral hydrate (Rx) | 273 | ||
Controlled substance schedule IV (USA), schedule F (Canada) | 273 | ||
Action: | 273 | ||
Uses: | 273 | ||
Contraindications: | 273 | ||
Dosage and routes | 273 | ||
Side effects | 273 | ||
Pharmacokinetics | 274 | ||
Interactions | 274 | ||
Nursing considerations | 274 | ||
Treatment of overdose: | 274 | ||
Chlorambucil (Rx) | 274 | ||
Chloramphenicol (Rx) | 276 | ||
Chloramphenicol ophthalmic | 278 | ||
Chloramphenicol otic | 278 | ||
Chlordiazepoxide (Rx) | 278 | ||
Controlled substance schedule IV | 278 | ||
Action: | 278 | ||
Uses: | 278 | ||
Contraindications: | 278 | ||
Dosage and routes | 278 | ||
Mild anxiety | 278 | ||
• Adult: | 278 | ||
• Geriatric: | 278 | ||
• Child >6 yr: | 278 | ||
Severe anxiety | 279 | ||
D | 355 | ||
Dabigatran | 355 | ||
Dacarbazine (Rx) | 356 | ||
Dactinomycin (Rx) | 358 | ||
Dalfampridine (Rx) | 361 | ||
Dalteparin (Rx) | 361 | ||
Dantrolene (Rx) | 363 | ||
Dapiprazole ophthalmic | 365 | ||
Daptomycin (Rx) | 365 | ||
Darbepoetin (Rx) | 367 | ||
Darunavir (Rx) | 369 | ||
Dasatinib (Rx) | 370 | ||
Daunorubicin (Rx) | 372 | ||
Daunorubicin citrate liposomal (Rx) | 372 | ||
Decitabine (Rx) | 374 | ||
Deferasirox (Rx) | 376 | ||
Deferoxamine (Rx) | 376 | ||
Delavirdine (Rx) | 376 | ||
Demecarium ophthalmic | 378 | ||
Denileukin diftitox (Rx) | 378 | ||
Denosumab (Rx) | 379 | ||
Desipramine (Rx) | 381 | ||
Desloratadine (Rx) | 383 | ||
Desmopressin (Rx) | 384 | ||
Desonide topical | 385 | ||
Desoximetasone topical | 385 | ||
Desoxyephedrine nasal agent | 385 | ||
Desvenlafaxine | 385 | ||
Dexamethasone (Rx) | 387 | ||
Dexamethasone sodium phosphate (Rx) | 387 | ||
Dexamethasone ophthalmic | 390 | ||
Dexamethasone topical | 390 | ||
Dexlansoprazole (Rx) | 390 | ||
Dexmedetomidine (Rx) | 391 | ||
Dexmethylphenidate (Rx) | 393 | ||
Controlled substance schedule II | 393 | ||
Action: | 393 | ||
Uses: | 393 | ||
Contraindications: | 393 | ||
Precautions: | 393 | ||
Dosage and routes | 393 | ||
Side effects | 394 | ||
Pharmacokinetics | 394 | ||
Interactions | 394 | ||
Nursing considerations | 394 | ||
Treatment of overdose: | 394 | ||
Dextran 40 (Rx) | 395 | ||
Dextran 70/75 (Rx) | 395 | ||
Dextroamphetamine (Rx) | 396 | ||
Controlled substance schedule II | 396 | ||
Action: | 396 | ||
Uses: | 396 | ||
Contraindications: | 396 | ||
Precautions: | 396 | ||
Dosage and routes | 396 | ||
Side effects | 396 | ||
Pharmacokinetics | 397 | ||
Interactions | 397 | ||
Nursing considerations | 397 | ||
Treatment of overdose: | 397 | ||
Dextromethorphan (OTC) | 398 | ||
Dextrose (D-glucose) (Rx) | 399 | ||
Diazepam (Rx) | 400 | ||
Controlled substance schedule IV | 400 | ||
Action: | 400 | ||
Uses: | 400 | ||
Contraindications: | 400 | ||
Precautions: | 400 | ||
Dosage and routes | 400 | ||
Side effects | 401 | ||
Pharmacokinetics | 402 | ||
Interactions | 402 | ||
Nursing considerations | 402 | ||
Treatment of overdose: | 403 | ||
Dibucaine topical | 403 | ||
Diclofenac epolamine (Rx) | 403 | ||
Diclofenac potassium (Rx) | 403 | ||
Diclofenac sodium (Rx) | 403 | ||
Diclofenac ophthalmic | 405 | ||
Didanosine (Rx) | 405 | ||
Diflunisal (Rx) | 407 | ||
Difluprednate ophthalmic | 407 | ||
Digoxin (Rx) | 407 | ||
Digoxin immune FAB (ovine) (Rx) | 411 | ||
Diltiazem (Rx) | 412 | ||
Dinoprostone (Rx) | 414 | ||
Diphenhydramine (OTC, Rx) | 415 | ||
Diphenoxylate/atropine (Rx) | 418 | ||
Difenoxin/atropine (Rx) | 418 | ||
Controlled substance schedule V | 418 | ||
Controlled substance schedule IV | 418 | ||
Action: | 418 | ||
Uses: | 418 | ||
Contraindications: | 418 | ||
Precautions: | 418 | ||
Dosage and routes | 418 | ||
Side effects | 418 | ||
Pharmacokinetics | 418 | ||
Interactions | 418 | ||
Nursing considerations | 418 | ||
Dipivefrin ophthalmic | 419 | ||
Dipyridamole (Rx) | 419 | ||
Disopyramide (Rx) | 420 | ||
Dobutamine (Rx) | 422 | ||
Docetaxel (Rx) | 423 | ||
Docosanol topical | 426 | ||
Docusate calcium (OTC) | 427 | ||
Docusate sodium (OTC) | 427 | ||
Dofetilide (Rx) | 428 | ||
Dolasetron (Rx) | 429 | ||
Donepezil (Rx) | 430 | ||
Dopamine (Rx) | 431 | ||
Doripenem (Rx) | 433 | ||
Dorzolamide ophthalmic | 435 | ||
Doxazosin (Rx) | 435 | ||
Doxepin (Rx) | 436 | ||
Doxercalciferol (Rx) | 438 | ||
Doxorubicin (Rx) | 440 | ||
Doxorubicin liposomal (Rx) | 440 | ||
Doxycycline (Rx) | 443 | ||
Doxycycline calcium | 443 | ||
Doxycycline hyclate | 443 | ||
Doxycycline monohydrate | 443 | ||
Dronedarone (Rx) | 446 | ||
Droperidol (Rx) | 447 | ||
Drotrecogin (Rx) | 448 | ||
Duloxetine (Rx) | 450 | ||
Dutasteride (Rx) | 452 | ||
E | 453 | ||
Econazole topical | 453 | ||
Ecothiophate ophthalmic | 453 | ||
Edetate calcium disodium (Rx) | 453 | ||
Edetate disodium (Rx) | 453 | ||
Efavirenz (Rx) | 453 | ||
Eletriptan (Rx) | 455 | ||
Emedastine ophthalmic | 456 | ||
Emtricitabine (Rx) | 456 | ||
Enalapril/enalaprilat (Rx) | 457 | ||
Enfuvirtide (Rx) | 460 | ||
Enoxaparin (Rx) | 461 | ||
Entacapone (Rx) | 463 | ||
Entecavir (Rx) | 464 | ||
Ephedrine nasal agent | 465 | ||
Epinastine ophthalmic | 465 | ||
Epinephrine (Rx) | 466 | ||
Epinephrine/epinephryl borate ophthalmic | 468 | ||
Epinephrine nasal agent | 468 | ||
Epirubicin (Rx) | 468 | ||
Eplerenone (Rx) | 470 | ||
Epoetin alfa (Rx) | 472 | ||
Eprosartan (Rx) | 473 | ||
Eptifibatide (Rx) | 474 | ||
Ergotamine (Rx) | 476 | ||
Dihydroergotamine | 476 | ||
Eribulin | 478 | ||
Erlotinib (Rx) | 479 | ||
Ertapenem (Rx) | 481 | ||
Erythromycin base (Rx) | 483 | ||
Erythromycin ethylsuccinate (Rx) | 483 | ||
Erythromycin lactobionate (Rx) | 483 | ||
Erythromycin stearate (Rx) | 483 | ||
Erythromycin ophthalmic | 486 | ||
Erythromycin topical | 486 | ||
Escitalopram (Rx) | 486 | ||
Esmolol (Rx) | 488 | ||
Esomeprazole (Rx) | 490 | ||
Estradiol (Rx) | 491 | ||
Estradiol cypionate (Rx) | 491 | ||
Estradiol gel (Rx) | 491 | ||
Estradiol spray (Rx) | 491 | ||
Estradiol topical emulsion (Rx) | 491 | ||
Estradiol valerate (Rx) | 491 | ||
Estradiol transdermal system (Rx) | 491 | ||
Estradiol vaginal tablet (Rx) | 491 | ||
Estradiol vaginal ring (Rx) | 491 | ||
Estramustine (Rx) | 494 | ||
Estrogens, conjugated (Rx) | 494 | ||
Estrogens, conjugated synthetic B (Rx) | 494 | ||
Eszopiclone (Rx) | 496 | ||
Controlled substance schedule IV | 496 | ||
Action: | 496 | ||
Uses: | 496 | ||
Contraindications: | 496 | ||
Dosage and routes | 496 | ||
Side effects | 496 | ||
Pharmacokinetics | 496 | ||
Interactions | 496 | ||
Nursing considerations | 496 | ||
Etanercept (Rx) | 497 | ||
Ethambutol (Rx) | 498 | ||
Etidronate (Rx) | 499 | ||
Etomidate (Rx) | 500 | ||
Etoposide (Rx) | 500 | ||
Etoposide phosphate (Rx) | 500 | ||
Etravirine (Rx) | 504 | ||
Everolimus (Rx) | 505 | ||
Exemestane (Rx) | 507 | ||
Exenatide (Rx) | 508 | ||
Ezetimibe (Rx) | 509 | ||
Ezogabine | 510 | ||
F | 511 | ||
Factor VIIa, recombinant (Rx) | 511 | ||
Factor IX complex (human) (Rx) | 512 | ||
Famciclovir (Rx) | 514 | ||
Famotidine (OTC, Rx) | 515 | ||
Fat emulsions (Rx) | 517 | ||
Febuxostat (Rx) | 518 | ||
Felbamate (Rx) | 519 | ||
Felodipine (Rx) | 520 | ||
Fenofibrate (Rx) | 521 | ||
Fenofibric acid (Rx) | 523 | ||
Fenoldopam (Rx) | 524 | ||
Fentanyl (Rx) | 526 | ||
Fentanyl transdermal (Rx) | 526 | ||
Fentanyl nasal spray (Rx) | 526 | ||
Fentanyl SL spray (Rx) | 526 | ||
Controlled substance schedule II | 526 | ||
Action: | 526 | ||
Uses: | 526 | ||
Contraindications: | 526 | ||
Dosage and routes | 526 | ||
Fentanyl | 526 | ||
Anesthetic | 526 | ||
G | 577 | ||
Gabapentin (Rx) | 577 | ||
Galantamine (Rx) | 579 | ||
Ganciclovir (Rx) | 580 | ||
Ganciclovir ophthalmic | 582 | ||
Ganirelix (Rx) | 582 | ||
Gatifloxacin ophthalmic | 583 | ||
Gemcitabine (Rx) | 583 | ||
Gemfibrozil (Rx) | 585 | ||
Gemifloxacin (Rx) | 586 | ||
Gentamicin (Rx) | 588 | ||
Gentamicin ophthalmic | 590 | ||
Gentamicin topical | 590 | ||
Glatiramer (Rx) | 590 | ||
Glimepiride (Rx) | 591 | ||
Glipizide (Rx) | 591 | ||
Glucarpidase | 593 | ||
Glyburide (Rx) | 594 | ||
Glycerin (OTC) | 596 | ||
Glycopyrrolate (Rx) | 596 | ||
Golimumab (Rx) | 598 | ||
Goserelin (Rx) | 600 | ||
Granisetron (Rx) | 601 | ||
Guaifenesin (OTC, Rx) | 603 | ||
H | 604 | ||
Halcinonide topical | 604 | ||
Haloperidol (Rx) | 604 | ||
Haloperidol decanoate (Rx) | 604 | ||
Haloperidol lactate (Rx) | 604 | ||
Heparin (Rx) | 606 | ||
Hepatitis B immune globulin (Rx) | 609 | ||
Homatropine ophthalmic | 610 | ||
Hydralazine (Rx) | 610 | ||
Hydrochlorothiazide (Rx) | 612 | ||
Hydrocodone (Rx) | 613 | ||
Hydrocodone/acetaminophen (Rx) | 613 | ||
Hydrocodone/ibuprofen (Rx) | 613 | ||
Controlled substance schedule III | 613 | ||
Action: | 613 | ||
Uses: | 613 | ||
Contraindications: | 613 | ||
Dosage and routes | 614 | ||
Side effects | 614 | ||
Pharmacokinetics | 614 | ||
Interactions | 614 | ||
Nursing considerations | 614 | ||
Treatment of overdose: | 615 | ||
Hydrocortisone (Rx) | 615 | ||
Hydrocortisone acetate (Rx) | 615 | ||
Hydrocortisone sodium succinate (Rx) | 615 | ||
Hydrocortisone nasal | 617 | ||
Hydrocortisone topical | 617 | ||
Hydromorphone (Rx) | 618 | ||
Controlled substance schedule II | 618 | ||
Action: | 618 | ||
Uses: | 618 | ||
Contraindications: | 618 | ||
Dosage and routes | 618 | ||
Side effects | 619 | ||
Pharmacokinetics | 619 | ||
Interactions | 619 | ||
Nursing considerations | 619 | ||
Treatment of overdose: | 620 | ||
Hydroxychloroquine (Rx) | 620 | ||
Hydroxyurea (Rx) | 621 | ||
Hydroxyzine (Rx) | 623 | ||
Hyoscyamine (Rx) | 625 | ||
I | 626 | ||
Ibandronate (Rx) | 626 | ||
Ibritumomab (Rx) | 627 | ||
Ibuprofen (OTC, Rx) | 629 | ||
Ibuprofen lysine (Rx) | 629 | ||
Ibutilide (Rx) | 631 | ||
Idarubicin (Rx) | 632 | ||
Ifosfamide (Rx) | 634 | ||
Iloperidone (Rx) | 636 | ||
Imatinib (Rx) | 638 | ||
Imipenem/cilastatin (Rx) | 639 | ||
Imipramine (Rx) | 641 | ||
Immune globulin IM (IMIG/IGIM) (Rx) | 643 | ||
Immune globulin IV (IGIV, IVIG) (Rx) | 643 | ||
Immune globulin SC (SCIG/IGSC) | 643 | ||
Inamrinone (Rx) | 645 | ||
Indacaterol | 647 | ||
Indapamide (Rx) | 649 | ||
Indinavir (Rx) | 650 | ||
Indomethacin (Rx) | 651 | ||
Infliximab (Rx) | 653 | ||
Insulins | 655 | ||
Rapid acting | 655 | ||
Insulin glulisine (Rx) | 655 | ||
Insulin aspart (Rx) | 655 | ||
Insulin lispro (Rx) | 655 | ||
Short acting | 655 | ||
Insulin, regular (OTC) | 655 | ||
Insulin, regular concentrated (Rx) | 655 | ||
Intermediate acting | 655 | ||
Insulin, isophane suspension (NPH) (OTC) | 655 | ||
Long acting | 655 | ||
Insulin detemir (Rx) | 655 | ||
Insulin glargine (Rx) | 655 | ||
Mixtures | 655 | ||
Insulin, isophane suspension and regular insulin (Rx) | 655 | ||
Isophane insulin suspension (NPH) and insulin mixtures (Rx) | 655 | ||
Insulin lispro mixture (Rx) | 655 | ||
Insulin aspart mixture (Rx) | 655 | ||
Interferon alfa-2b (recombinant) (Rx) | 658 | ||
Interferon alfacon-1 (Rx) | 660 | ||
Interferon alfa-n3 (Rx) | 661 | ||
Interferon beta-1a (Rx) | 662 | ||
Interferon beta-1b (Rx) | 662 | ||
Interferon gamma-1b (Rx) | 664 | ||
Ipilimumab | 665 | ||
Ipratropium (Rx) | 666 | ||
Irbesartan (Rx) | 668 | ||
Irinotecan (Rx) | 669 | ||
Iron dextran (Rx) | 670 | ||
Iron sucrose (Rx) | 672 | ||
Isoflurophate ophthalmic | 673 | ||
Isoniazid (Rx) | 673 | ||
Isosorbide dinitrate (Rx) | 674 | ||
Isosorbide mononitrate (Rx) | 674 | ||
Isotretinoin (Rx) | 675 | ||
Isradipine (Rx) | 676 | ||
Itraconazole (Rx) | 677 | ||
Ixabepilone (Rx) | 679 | ||
K | 680 | ||
Ketoconazole (Rx) | 680 | ||
Ketoconazole topical | 682 | ||
Ketoprofen (OTC, Rx) | 682 | ||
Ketorolac (Rx) | 683 | ||
L | 685 | ||
Labetalol (Rx) | 685 | ||
Lacosamide (Rx) | 687 | ||
Lactulose (Rx) | 688 | ||
Lamivudine 3TC (Rx) | 690 | ||
Lamotrigine (Rx) | 691 | ||
Lansoprazole (Rx, OTC) | 693 | ||
Lanthanum (Rx) | 695 | ||
Lapatinib (Rx) | 695 | ||
Latanoprost ophthalmic | 696 | ||
Leflunomide (Rx) | 697 | ||
Lenalidomide (Rx) | 698 | ||
Lepirudin (Rx) | 700 | ||
Letrozole (Rx) | 701 | ||
Leucovorin (Rx) | 702 | ||
Leuprolide (Rx) | 704 | ||
Levalbuterol (Rx) | 706 | ||
Levetiracetam (Rx) | 707 | ||
Levobetaxolol ophthalmic | 708 | ||
Levobunolol ophthalmic | 708 | ||
Levocabastine ophthalmic | 708 | ||
Levocetirizine (Rx) | 708 | ||
Levofloxacin (Rx) | 709 | ||
Levofloxacin ophthalmic | 712 | ||
Levoleucovorin (Rx) | 712 | ||
Levothyroxine (T4) (Rx) | 713 | ||
Lidocaine (parenteral) (Rx) | 715 | ||
Lidocaine topical | 717 | ||
Linagliptin | 717 | ||
Lindane (Rx) | 719 | ||
Linezolid (Rx) | 720 | ||
Liothyronine (T3) (Rx) | 722 | ||
Liotrix (Rx) | 724 | ||
Liraglutide (Rx) | 725 | ||
Lisdexamfetamine (Rx) | 727 | ||
Controlled substance schedule II | 727 | ||
Action: | 727 | ||
Uses: | 727 | ||
Contraindications: | 727 | ||
Dosage and routes | 727 | ||
Side effects | 727 | ||
Pharmacokinetics | 727 | ||
Interactions | 727 | ||
Nursing considerations | 728 | ||
Treatment of overdose: | 728 | ||
Lisinopril (Rx) | 728 | ||
Lithium (Rx) | 730 | ||
Lodoxamide ophthalmic | 732 | ||
Loperamide (OTC, Rx) | 732 | ||
Loratadine (OTC, Rx) | 733 | ||
Lorazepam (Rx) | 734 | ||
Controlled substance schedule IV | 734 | ||
Action: | 734 | ||
Uses: | 734 | ||
Contraindications: | 734 | ||
Dosage and routes | 734 | ||
Side effects | 735 | ||
Pharmacokinetics | 735 | ||
Interactions | 735 | ||
Nursing considerations | 736 | ||
Treatment of overdose: | 736 | ||
Losartan | 736 | ||
Loteprednol ophthalmic | 738 | ||
Lovastatin (Rx) | 738 | ||
Loxapine (Rx) | 739 | ||
Lubiprostone (Rx) | 741 | ||
Lurasidone (Rx) | 742 | ||
Lymphocyte immune globulin (anti-thymocyte, equine) (Rx) | 743 | ||
M | 744 | ||
Mafenide topical | 744 | ||
Magnesium salts | 744 | ||
Magnesium chloride (Rx) | 744 | ||
Magnesium citrate (OTC) | 744 | ||
Magnesium gluconate (OTC) | 744 | ||
Magnesium oxide (OTC) | 744 | ||
Magnesium hydroxide (OTC) | 744 | ||
Magnesium sulfate (OTC, Rx) | 744 | ||
Mannitol (Rx) | 746 | ||
Maraviroc (Rx) | 748 | ||
Mecasermin (Rx) | 750 | ||
Meclizine (OTC, Rx) | 751 | ||
Medroxyproges-terone (Rx) | 752 | ||
Medrysone ophthalmic | 753 | ||
Megestrol (Rx) | 754 | ||
Meloxicam (Rx) | 755 | ||
Melphalan (Rx) | 756 | ||
Memantine (Rx) | 759 | ||
Menotropins (Rx) | 760 | ||
Meperidine (Rx) | 761 | ||
Controlled substance schedule II | 761 | ||
Action: | 761 | ||
Uses: | 761 | ||
Contraindications: | 761 | ||
Dosage and routes | 761 | ||
Side effects | 762 | ||
Pharmacokinetics | 762 | ||
Interactions | 762 | ||
Nursing considerations | 763 | ||
Treatment of overdose: | 763 | ||
Mercaptopurine (6-MP) (Rx) | 763 | ||
Meropenem (Rx) | 765 | ||
Mesalamine, 5-ASA (Rx) | 766 | ||
Metformin (Rx) | 768 | ||
Methadone (Rx) | 770 | ||
Controlled substance schedule II | 770 | ||
Action: | 770 | ||
Uses: | 770 | ||
Contraindications: | 770 | ||
Dosage and routes | 770 | ||
Side effects | 770 | ||
Pharmacokinetics | 770 | ||
Interactions | 770 | ||
Nursing considerations | 771 | ||
Treatment of overdose: | 771 | ||
Methimazole (Rx) | 771 | ||
Methocarbamol (Rx) | 773 | ||
Methotrexate (Rx) | 775 | ||
Methoxy polyethylene glycol-epoetin beta (Rx) | 778 | ||
Methylcellulose (OTC) | 780 | ||
Methyldopa/methyldopate (Rx) | 780 | ||
Methylergonovine (Rx) | 783 | ||
Methylnaltrexone (Rx) | 784 | ||
Methylphenidate (Rx) | 785 | ||
Controlled substance schedule II | 785 | ||
Action: | 785 | ||
Uses: | 785 | ||
Contraindications: | 785 | ||
Dosage and routes | 785 | ||
Regular release: ritalin, methylin, methylin oral sol, methylin chew tabs | 785 | ||
Extended release: ritalin SR, metadate ER, methylin ER | 785 | ||
Extended-release once-daily tabs: concerta | 825 | ||
Extended-release once-daily capsules: ritalin LA | 785 | ||
Extended-release once-daily capsules: metadate CD | 825 | ||
Transdermal: daytrana | 825 | ||
Conversion to once-daily treatment from other forms for ADHD | 825 | ||
Extended-release once-daily capsules: metadate CD | 785 | ||
Extended-release once-daily capsules: ritalin LA | 786 | ||
Extended-release once-daily tablets: concerta | 786 | ||
Transdermal: daytrana | 786 | ||
Narcolepsy | 786 | ||
Immediate release: ritalin, methylin oral sol, methylin chew tabs | 786 | ||
Extended-release tabs: ritalin SR, metadate ER | 786 | ||
Poststroke depression; major depression (unlabeled) | 786 | ||
• Adult and geriatric: | 786 | ||
Available forms: | 786 | ||
Administer: | 786 | ||
PO route | 786 | ||
Transdermal route | 786 | ||
Side effects | 786 | ||
Pharmacokinetics | 787 | ||
Interactions | 787 | ||
Nursing considerations | 787 | ||
Treatment of overdose: | 787 | ||
Methylprednisolone (Rx) | 788 | ||
Metipranolol ophthalmic | 790 | ||
Metoclopramide (Rx) | 790 | ||
Metolazone (Rx) | 793 | ||
Metoprolol (Rx) | 794 | ||
Metronidazole (Rx) | 797 | ||
Metronidazole topical/vaginal | 800 | ||
Micafungin (Rx) | 800 | ||
Miconazole topical | 801 | ||
Miconazole vaginal antifungal | 802 | ||
Midazolam (Rx) | 802 | ||
Controlled substance schedule IV | 802 | ||
Action: | 802 | ||
Uses: | 802 | ||
Contraindications: | 802 | ||
Dosage and routes | 802 | ||
Side effects | 803 | ||
Pharmacokinetics | 803 | ||
Interactions | 803 | ||
Nursing considerations | 803 | ||
Treatment of overdose: | 804 | ||
Mifepristone | 804 | ||
Miglitol (Rx) | 805 | ||
Milrinone (Rx) | 806 | ||
Minocycline (Rx) | 808 | ||
Minoxidil (Rx, OTC) | 810 | ||
Mirtazapine (Rx) | 811 | ||
Misoprostol (Rx) | 813 | ||
Mitomycin (Rx) | 814 | ||
Mitoxantrone (Rx) | 816 | ||
Modafinil (Rx) | 818 | ||
Controlled substance IV | 818 | ||
Action: | 818 | ||
Uses: | 818 | ||
Contraindications: | 818 | ||
Dosage and routes | 818 | ||
Side effects | 818 | ||
Pharmacokinetics | 818 | ||
Interactions | 818 | ||
Nursing considerations | 818 | ||
Moexipril (Rx) | 819 | ||
Montelukast (Rx) | 820 | ||
Morphine (Rx) | 822 | ||
Controlled substance schedule II | 822 | ||
Action: | 822 | ||
Uses: | 822 | ||
Contraindications: | 822 | ||
Dosage and routes | 822 | ||
Side effects | 823 | ||
Pharmacokinetics | 823 | ||
Interactions | 823 | ||
Nursing considerations | 824 | ||
Treatment of overdose: | 824 | ||
Moxifloxacin (Rx) | 824 | ||
Moxifloxacin ophthalmic | 826 | ||
Multivitamins (OTC, Rx) | 826 | ||
Mupirocin topical | 827 | ||
Muromonab-CD3 (Rx) | 827 | ||
Mycophenolate mofetil (Rx) | 828 | ||
N | 830 | ||
Nabilone (Rx) | 830 | ||
Nabumetone (Rx) | 831 | ||
Nadolol (Rx) | 833 | ||
Nafarelin (Rx) | 834 | ||
Nafcillin (Rx) | 835 | ||
Nalbuphine (Rx) | 837 | ||
Naloxone (Rx) | 839 | ||
Naltrexone (Rx) | 840 | ||
Naphazoline nasal agent | 842 | ||
Naphazoline ophthalmic | 842 | ||
Naproxen (Rx, OTC) | 842 | ||
Naratriptan (Rx) | 844 | ||
Natalizumab (Rx) | 845 | ||
Natamycin ophthalmic | 847 | ||
Nebivolol (Rx) | 847 | ||
Nelarabine (Rx) | 848 | ||
Nelfinavir (Rx) | 850 | ||
Neomycin (Rx) | 851 | ||
Neomycin topical | 852 | ||
Neostigmine (Rx) | 852 | ||
Nepafenac ophthalmic | 853 | ||
Nesiritide (Rx) | 854 | ||
Nevirapine (Rx) | 855 | ||
Niacin (OTC, Rx) | 857 | ||
Niacinamide (OTC, Rx) | 857 | ||
Nicardipine (Rx) | 858 | ||
Nicotine | 860 | ||
Nicotine chewing gum (OTC, Rx) | 860 | ||
Nicotine inhaler (OTC, Rx) | 860 | ||
Nicotine lozenge (OTC) | 860 | ||
Nicotine nasal spray (Rx) | 860 | ||
Nicotine transdermal (OTC, Rx) | 860 | ||
Nifedipine (Rx) | 862 | ||
Nilotinib (Rx) | 864 | ||
Nilutamide (Rx) | 866 | ||
Nisoldipine (Rx) | 867 | ||
Nitazoxanide (Rx) | 868 | ||
Nitrofurantoin (Rx) | 869 | ||
Nitrofurazone topical | 870 | ||
Nitroglycerin (Rx) | 870 | ||
Extended release caps (Rx) | 870 | ||
Topical ointment (Rx) | 870 | ||
Rectal ointment | 870 | ||
SL (Rx) | 870 | ||
Translingual spray (Rx) | 870 | ||
Transdermal (Rx) | 870 | ||
Nitroprusside (Rx) | 873 | ||
Nizatidine (OTC, Rx) | 875 | ||
Norepinephrine (Rx) | 876 | ||
Norethindrone (Rx) | 878 | ||
Norfloxacin ophthalmic | 879 | ||
Nortriptyline (Rx) | 879 | ||
Nystatin (Rx) | 881 | ||
Nystatin topical | 882 | ||
Nystatin vaginal antifungal | 882 | ||
O | 882 | ||
Octreotide (Rx) | 882 | ||
Ofloxacin (Rx) | 885 | ||
Ofloxacin ophthalmic | 886 | ||
Olanzapine (Rx) | 886 | ||
Olmesartan (Rx) | 889 | ||
Olopatadine nasal agent | 890 | ||
Olopatadine ophthalmic | 890 | ||
Olsalazine (Rx) | 890 | ||
Omalizumab (Rx) | 891 | ||
Omeprazole (OTC, Rx) | 892 | ||
Ondansetron (Rx) | 893 | ||
Orlistat (Rx, OTC) | 895 | ||
Oseltamivir (Rx) | 896 | ||
Oxacillin (Rx) | 897 | ||
Oxaliplatin (Rx) | 899 | ||
Oxaprozin (Rx) | 902 | ||
Oxazepam (Rx) | 903 | ||
Controlled substance schedule IV | 903 | ||
Action: | 903 | ||
Uses: | 903 | ||
Contraindications: | 903 | ||
Dosage and routes | 903 | ||
Side effects | 903 | ||
Pharmacokinetics | 904 | ||
Interactions | 904 | ||
Nursing considerations | 904 | ||
Oxcarbazepine (Rx) | 904 | ||
Oxybutynin (Rx) | 906 | ||
Oxycodone (Rx) | 907 | ||
Oxycodone/aspirin (Rx) | 907 | ||
Oxycodone/acetaminophen (Rx) | 907 | ||
Oxycodone/ibuprofen (Rx) | 907 | ||
Controlled substance schedule II | 907 | ||
Action: | 907 | ||
Uses: | 907 | ||
Contraindications: | 907 | ||
Dosage and routes | 908 | ||
Side effects | 908 | ||
Pharmacokinetics | 908 | ||
Interactions | 908 | ||
Nursing considerations | 908 | ||
Treatment of overdose: | 909 | ||
Oxymetazoline nasal agent | 909 | ||
Oxymetazoline ophthalmic | 909 | ||
Oxymorphone (Rx) | 909 | ||
Controlled substance schedule II | 909 | ||
Action: | 909 | ||
Uses: | 909 | ||
Contraindications: | 909 | ||
Dosage and routes | 909 | ||
Side effects | 910 | ||
Pharmacokinetics | 910 | ||
Interactions | 910 | ||
Nursing considerations | 910 | ||
Treatment of overdose: | 910 | ||
Oxytocin (Rx) | 911 | ||
P | 912 | ||
Paclitaxel (Rx) | 912 | ||
Paclitaxel nanoparticle albumin-bound (Rx) | 912 | ||
Paliperidone (Rx) | 914 | ||
Palonosetron (Rx) | 917 | ||
Pamidronate (Rx) | 918 | ||
Pancrelipase (Rx) | 921 | ||
Pancuronium (Rx) | 922 | ||
Panitumumab (Rx) | 923 | ||
Pantoprazole (Rx) | 924 | ||
Paricalcitol (Rx) | 926 | ||
Paroxetine (Rx) | 927 | ||
Pegaspargase (Rx) | 930 | ||
Pegfilgrastim (Rx) | 931 | ||
Peginterferon alfa-2a (Rx) | 932 | ||
Peginterferon alfa-2b (Rx) | 932 | ||
Pegloticase (Rx) | 934 | ||
Pemetrexed (Rx) | 935 | ||
Penciclovir topical | 937 | ||
Penicillin G benzathine (Rx) | 938 | ||
Penicillin G (Rx) | 938 | ||
Penicillin G procaine (Rx) | 938 | ||
Penicillin V (Rx) | 938 | ||
Pentamidine (Rx) | 941 | ||
Pentazocine (Rx) | 942 | ||
Controlled substance schedule IV | 942 | ||
Action: | 942 | ||
Uses: | 942 | ||
Contraindications: | 942 | ||
Dosage and routes | 942 | ||
Side effects | 943 | ||
Pharmacokinetics | 943 | ||
Interactions | 943 | ||
Nursing considerations | 943 | ||
Treatment of overdose: | 944 | ||
Pentoxifylline (Rx) | 944 | ||
Perindopril (Rx) | 945 | ||
Phenazopyridine (Rx, OTC) | 946 | ||
Phenobarbital (Rx) | 947 | ||
Controlled substance schedule IV | 947 | ||
Action: | 947 | ||
Uses: | 947 | ||
Contraindications: | 947 | ||
Dosage and routes | 948 | ||
Side effects | 948 | ||
Pharmacokinetics | 948 | ||
Interactions | 948 | ||
Nursing considerations | 949 | ||
Phenylephrine (Rx) | 949 | ||
Phenylephrine nasal agent | 950 | ||
Phenylephrine ophthalmic | 950 | ||
Phenytoin (Rx) | 950 | ||
Phosphate/biphosphate (OTC) | 953 | ||
Physostigmine ophthalmic | 953 | ||
Phytonadione (Rx) | 954 | ||
Pilocarpine ophthalmic | 955 | ||
Pimecrolimus topical | 955 | ||
Pioglitazone (Rx) | 955 | ||
Piperacillin/tazobactam (Rx) | 957 | ||
Piroxicam (Rx) | 959 | ||
Pitavastatin (Rx) | 960 | ||
Plasma protein fraction (Rx) | 961 | ||
Plerixafor (Rx) | 962 | ||
Posaconazole (Rx) | 963 | ||
Potassium acetate | 965 | ||
Potassium bicarbonate (OTC, Rx) | 965 | ||
Potassium bicarbonate and potassium chloride (OTC, Rx) | 965 | ||
Potassium bicarbonate and potassium citrate (OTC, Rx) | 965 | ||
Potassium chloride (OTC, Rx) | 965 | ||
Potassium gluconate (OTC, Rx) | 965 | ||
Potassium iodide (Rx) | 967 | ||
Pramipexole (Rx) | 969 | ||
Pramlintide (Rx) | 970 | ||
Pramoxine topical | 971 | ||
Prasugrel (Rx) | 971 | ||
Pravastatin (Rx) | 973 | ||
Prazosin (Rx) | 974 | ||
Prednisolone (Rx) | 975 | ||
Prednisolone ophthalmic (Rx) | 977 | ||
Prednisone (Rx) | 977 | ||
Pregabalin (Rx) | 979 | ||
Controlled substance schedule V | 979 | ||
Action: | 979 | ||
Uses: | 979 | ||
Contraindications: | 979 | ||
Dosage and routes | 979 | ||
Side effects | 979 | ||
Pharmacokinetics | 979 | ||
Interactions | 980 | ||
Nursing considerations | 980 | ||
Treatment of overdose: | 980 | ||
Primaquine (Rx) | 980 | ||
Primidone (Rx) | 981 | ||
Procainamide (Rx) | 983 | ||
Procaine (Rx) | 985 | ||
Procarbazine (Rx) | 986 | ||
Prochlorperazine (Rx) | 988 | ||
Progesterone (Rx) | 990 | ||
Promethazine (Rx) | 991 | ||
Propafenone (Rx) | 994 | ||
Proparacaine ophthalmic | 995 | ||
Propofol (Rx) | 995 | ||
Propranolol (Rx) | 997 | ||
Propylhexadrine nasal agent | 1000 | ||
Propylthiouracil (Rx) | 1000 | ||
Protamine (Rx) | 1002 | ||
Pseudoephedrine (OTC, Rx) | 1003 | ||
Pseudoephedrine nasal agent | 1004 | ||
Psyllium (OTC, Rx) | 1004 | ||
Pyrazinamide (Rx) | 1005 | ||
Pyridostigmine (Rx) | 1006 | ||
Pyridoxine (vit B6) (Rx, OTC) | 1008 | ||
Pyrimethamine (Rx) | 1009 | ||
Q | 1010 | ||
Quetiapine (Rx) | 1010 | ||
Quinapril (Rx) | 1012 | ||
Quinidine gluconate (Rx) | 1014 | ||
Quinidine sulfate (Rx) | 1014 | ||
Quinine (Rx) | 1016 | ||
R | 1017 | ||
Rabeprazole (Rx) | 1017 | ||
Radioactive iodine (sodium iodide) 131I (Rx) | 1019 | ||
Raloxifene (Rx) | 1020 | ||
Raltegravir (Rx) | 1021 | ||
Ramelteon (Rx) | 1022 | ||
Ramipril (Rx) | 1023 | ||
Ranibizumab (Rx) | 1025 | ||
Ranitidine (Rx, OTC) | 1026 | ||
Ranitidine bismuth citrate | 1026 | ||
Ranolazine (Rx) | 1029 | ||
Rasagiline (Rx) | 1030 | ||
Rasburicase (Rx) | 1031 | ||
Remifentanil (Rx) | 1032 | ||
Controlled substance schedule II | 1032 | ||
Action: | 1032 | ||
Uses: | 1032 | ||
Contraindications: | 1032 | ||
Dosage and routes | 1032 | ||
Side effects | 1033 | ||
Pharmacokinetics | 1033 | ||
Interactions | 1033 | ||
Nursing considerations | 1033 | ||
Repaglinide (Rx) | 1034 | ||
Retapamulin topical | 1035 | ||
Rho(D) immune globulin standard dose IM (Rx) | 1035 | ||
Rho(D) immune globulin microdose IM (Rx) | 1035 | ||
Rho(D) immune globulin IV (Rx) | 1035 | ||
Riboflavin (vit B2) (OTC) | 1038 | ||
Rifabutin (Rx) | 1038 | ||
Rifampin (Rx) | 1040 | ||
Rifapentine (Rx) | 1041 | ||
Rifaximin (Rx) | 1043 | ||
Rilpivirine | 1043 | ||
Riluzole (Rx) | 1044 | ||
Rimantadine (Rx) | 1044 | ||
Rimexolone ophthalmic | 1045 | ||
Risedronate (Rx) | 1046 | ||
Risperidone (Rx) | 1047 | ||
Ritonavir (Rx) | 1050 | ||
Rituximab (Rx) | 1051 | ||
Rivaroxaban | 1053 | ||
Rivastigmine (Rx) | 1053 | ||
Rizatriptan (Rx) | 1055 | ||
Rocuronium (Rx) | 1056 | ||
Roflumilast | 1057 | ||
Romiplostim (Rx) | 1057 | ||
Ropinirole (Rx) | 1058 | ||
Ropivacaine (Rx) | 1059 | ||
Rosiglitazone (Rx) | 1060 | ||
Rosuvastatin (Rx) | 1062 | ||
Rufinamide (Rx) | 1063 | ||
S | 1064 | ||
Salicylic acid topical | 1064 | ||
Salmeterol (Rx) | 1064 | ||
Salsalate (Rx) | 1065 | ||
Saquinavir (Rx) | 1067 | ||
Sargramostim (Rx) | 1068 | ||
Saxagliptin (Rx) | 1070 | ||
Scopolamine (Rx) | 1071 | ||
Scopolamine ophthalmic | 1072 | ||
Selegiline (Rx) | 1072 | ||
Selenium topical | 1074 | ||
Sennosides (OTC) | 1074 | ||
Sertraline (Rx) | 1075 | ||
Sildenafil (Rx) | 1077 | ||
Silodosin (Rx) | 1079 | ||
Silver nitrate 1% ophthalmic | 1079 | ||
Silver nitrate sulfacetamide sodium ophthalmic | 1080 | ||
Silver sulfadiazine topical | 1080 | ||
Simethicone (OTC, Rx) | 1080 | ||
Simvastatin (Rx) | 1080 | ||
Sipuleucel-T (Rx) | 1082 | ||
Sirolimus (Rx) | 1083 | ||
Sitagliptin (Rx) | 1084 | ||
Sodium bicarbonate (Rx, OTC) | 1086 | ||
Sodium polystyrene sulfonate (Rx) | 1088 | ||
Solifenacin (Rx) | 1089 | ||
Somatropin (Rx) | 1090 | ||
Sorafenib (Rx) | 1091 | ||
Sotalol (Rx) | 1093 | ||
Spironolactone (Rx) | 1095 | ||
Stavudine d4t (Rx) | 1097 | ||
Streptomycin (Rx) | 1098 | ||
Succimer (Rx) | 1100 | ||
Succinylcholine (Rx) | 1101 | ||
Sucralfate (Rx) | 1102 | ||
Sulfasalazine (Rx) | 1103 | ||
Sulindac (Rx) | 1104 | ||
Sumatriptan (Rx) | 1106 | ||
Sunitinib (Rx) | 1107 | ||
Suprofen ophthalmic | 1109 | ||
T | 1109 | ||
Tacrolimus (Rx) (PO, IV) | 1109 | ||
Tacrolimus (topical) (Rx) | 1109 | ||
Tadalafil (Rx) | 1112 | ||
Tamoxifen (Rx) | 1114 | ||
Tamsulosin (Rx) | 1115 | ||
Tapentadol (Rx) | 1116 | ||
Controlled substance schedule II | 1116 | ||
Action: | 1116 | ||
Uses: | 1116 | ||
Contraindications: | 1116 | ||
Dosage and routes | 1117 | ||
Side effects | 1117 | ||
Pharmacokinetics | 1117 | ||
Interactions | 1117 | ||
Nursing considerations | 1117 | ||
Telaprevir | 1118 | ||
Telavancin (Rx) | 1118 | ||
Telbivudine (Rx) | 1119 | ||
Telmisartan (Rx) | 1120 | ||
Temazepam (Rx) | 1121 | ||
Controlled substance schedule IV (USA), schedule F (Canada) | 1121 | ||
Action: | 1121 | ||
Uses: | 1121 | ||
Contraindications: | 1121 | ||
Dosage and routes | 1122 | ||
Side effects | 1122 | ||
Pharmacokinetics | 1122 | ||
Interactions | 1122 | ||
Nursing considerations | 1122 | ||
Treatment of overdose: | 1123 | ||
Temozolomide (Rx) | 1123 | ||
Temsirolimus (Rx) | 1124 | ||
Tenecteplase (TNK-tPA)(Rx) | 1126 | ||
Tenofovir (Rx) | 1127 | ||
Terazosin (Rx) | 1128 | ||
Terbinafine (Rx) | 1129 | ||
Terbinafine topical | 1130 | ||
Terbutaline (Rx) | 1130 | ||
Terconazole vaginal antifungal | 1132 | ||
Teriparatide (Rx) | 1132 | ||
Tesamorelin | 1133 | ||
Testosterone cypionate (Rx) | 1133 | ||
Testosterone enanthate (Rx) | 1133 | ||
Testosterone gel (Rx) | 1133 | ||
Testosterone pellets (Rx) | 1133 | ||
Testosterone transdermal (Rx) | 1133 | ||
Testosterone buccal (Rx) | 1133 | ||
Testosterone topical solution | 1133 | ||
Controlled substance schedule III | 1133 | ||
Action: | 1133 | ||
Uses: | 1133 | ||
Contraindications: | 1133 | ||
Dosage and routes | 1134 | ||
Side effects | 1134 | ||
Pharmacokinetics | 1134 | ||
Interactions | 1134 | ||
Nursing considerations | 1135 | ||
Tetracaine (Rx) | 1135 | ||
Tetracaine ophthalmic | 1136 | ||
Tetracaine topical | 1136 | ||
Tetracycline (Rx) | 1136 | ||
Tetrahydrozoline nasal agent | 1138 | ||
Tetrahydrozoline ophthalmic | 1138 | ||
Theophylline (Rx) | 1138 | ||
Thiamine (vit B1) (PO-OTC; IV, IM-Rx) | 1139 | ||
Thiopental (Rx) | 1140 | ||
Controlled substance schedule III | 1140 | ||
Action: | 1140 | ||
Uses: | 1140 | ||
Contraindications: | 1140 | ||
Dosage and routes | 1141 | ||
Side effects | 1141 | ||
Pharmacokinetics | 1141 | ||
Interactions | 1141 | ||
Nursing considerations | 1141 | ||
Thioridazine (Rx) | 1142 | ||
Thyroid USP (desiccated) (Rx) | 1144 | ||
Tiagabine (Rx) | 1145 | ||
Ticagrelor | 1146 | ||
Ticarcillin/clavulanate (Rx) | 1146 | ||
Ticlopidine (Rx) | 1148 | ||
Tigecycline (Rx) | 1150 | ||
Timolol (Rx) | 1152 | ||
Timolol ophthalmic | 1153 | ||
Tinidazole (Rx) | 1153 | ||
Tinzaparin (Rx) | 1155 | ||
Tioconazole vaginal antifungal | 1156 | ||
Tiotropium (Rx) | 1156 | ||
Tipranavir (Rx) | 1157 | ||
Tirofiban (Rx) | 1159 | ||
Tizanidine (Rx) | 1160 | ||
Tobramycin (Rx) | 1161 | ||
Tobramycin ophthalmic | 1164 | ||
Tocilizumab (Rx) | 1164 | ||
Tolcapone (Rx) | 1165 | ||
Tolnaftate topical | 1166 | ||
Tolterodine (Rx) | 1166 | ||
Tolvaptan (Rx) | 1167 | ||
Topiramate (Rx) | 1168 | ||
Topotecan (Rx) | 1170 | ||
Toremifene (Rx) | 1172 | ||
Torsemide (Rx) | 1173 | ||
Trace elements (Rx) | 1175 | ||
Tramadol (Rx) | 1175 | ||
Trandolapril (Rx) | 1177 | ||
Trastuzumab (Rx) | 1178 | ||
Travoprost ophthalmic | 1180 | ||
Trazodone (Rx) | 1180 | ||
Treprostinil (Rx) | 1182 | ||
Tretinoin (vit A acid, retinoic acid) (Rx) | 1183 | ||
Tretinoin topical | 1185 | ||
Triamcinolone (Rx) | 1185 | ||
Triamcinolone nasal agent | 1186 | ||
Triamcinolone ophthalmic | 1186 | ||
Triamcinolone topical | 1187 | ||
Triamcinolone (topical-oral) (OTC) | 1187 | ||
Triazolam (Rx) | 1187 | ||
Controlled substance schedule IV (USA), targeted (CDSA IV) (Canada) | 1187 | ||
Action: | 1187 | ||
Uses: | 1187 | ||
Contraindications: | 1187 | ||
Dosage and routes | 1187 | ||
Side effects | 1188 | ||
Pharmacokinetics | 1188 | ||
Interactions | 1188 | ||
Nursing considerations | 1188 | ||
Treatment of overdose: | 1189 | ||
Trifluridine ophthalmic | 1189 | ||
Trimethobenzamide (Rx) | 1189 | ||
Trimethoprim-sulfamethoxazole (Rx) | 1190 | ||
Tropicamide ophthalmic | 1192 | ||
Trospium (Rx) | 1192 | ||
U | 1193 | ||
Undecylenic acid topical | 1193 | ||
Unoprostone ophthalmic | 1193 | ||
Urokinase (Rx) | 1193 | ||
Ursodiol (Rx) | 1195 | ||
V | 1196 | ||
Valacyclovir (Rx) | 1196 | ||
Valganciclovir (Rx) | 1197 | ||
Valproate (Rx) | 1199 | ||
Valproic acid (Rx) | 1199 | ||
Divalproex sodium (Rx) | 1199 | ||
Valsartan (Rx) | 1201 | ||
Vancomycin (Rx) | 1202 | ||
Vardenafil (Rx) | 1204 | ||
Varenicline (Rx) | 1205 | ||
Vasopressin (Rx) | 1206 | ||
Vecuronium (Rx) | 1207 | ||
Vemurafemib | 1208 | ||
Venlafaxine (Rx) | 1208 | ||
Verapamil (Rx) | 1211 | ||
Vidarabine ophthalmic | 1213 | ||
Vigabatrin (Rx) | 1213 | ||
Vilazodone (Rx) | 1214 | ||
VinBLAStine (VLB) (Rx) | 1216 | ||
Vincristine (VCR) (rx) | 1218 | ||
Vinorelbine (Rx) | 1220 | ||
Vitamin A (Rx, OTC) | 1222 | ||
Vitamin E (OTC) | 1223 | ||
Voriconazole (Rx) | 1224 | ||
W | 1227 | ||
Warfarin (Rx) | 1227 | ||
X | 1228 | ||
Xylometazoline nasal agent | 1228 | ||
Z | 1229 | ||
Zafirlukast (Rx) | 1229 | ||
Zaleplon (Rx) | 1230 | ||
Controlled substance schedule IV | 1230 | ||
Action: | 1230 | ||
Uses: | 1230 | ||
Contraindications: | 1230 | ||
Dosage and routes | 1230 | ||
Side effects | 1230 | ||
Pharmacokinetics | 1230 | ||
Interactions | 1230 | ||
Nursing considerations | 1231 | ||
Zanamivir (Rx) | 1231 | ||
Zidovudine (Rx) | 1232 | ||
Zinc (Rx, OTC) | 1234 | ||
Ziprasidone (Rx) | 1235 | ||
Zoledronic acid (Rx) | 1237 | ||
Zolmitriptan (Rx) | 1239 | ||
Zolpidem (Rx) | 1240 | ||
Controlled substance schedule IV | 1240 | ||
Action: | 1240 | ||
Uses: | 1240 | ||
Contraindications: | 1240 | ||
Dosage and routes | 1240 | ||
Side effects | 1241 | ||
Pharmacokinetics | 1241 | ||
Interactions | 1241 | ||
Nursing considerations | 1241 | ||
Treatment of overdose: | 1241 | ||
Zonisamide (Rx) | 1241 | ||
Appendix A Selected new drugs | 1243 | ||
Abiraterone | 1243 | ||
Aflibercept | 1244 | ||
Aminophylline (theophylline ethylenediamine) (Rx) | 1246 | ||
Asparaginase Erwinia chrysanthemi | 1247 | ||
Axitinib | 1249 | ||
Azilsartan | 1251 | ||
Belatacept | 1252 | ||
Belimumab | 1252 | ||
Boceprevir | 1252 | ||
Brentuximab | 1252 | ||
Crizotinib | 1252 | ||
Desvenlafaxine | 1252 | ||
Ezogabine | 1252 | ||
Fidaxomicin | 1252 | ||
Glucarpidase | 1252 | ||
Indacaterol | 1252 | ||
Ipilimumab | 1252 | ||
Linagliptin | 1252 | ||
Rilpivirine | 1253 | ||
Rivaroxaban | 1254 | ||
Roflumilast | 1257 | ||
Telaprevir | 1258 | ||
Tesamorelin | 1260 | ||
Ticagrelor | 1261 | ||
Vemurafenib | 1263 | ||
Appendix B Ophthalmic, otic, nasal, and topical products | 1265 | ||
Appendix C Vaccines and toxoids | 1280 | ||
Index | 1287 | ||
0-9, and symbols | 1287 | ||
A | 1287 | ||
B | 1293 | ||
C | 1295 | ||
D | 1300 | ||
E | 1303 | ||
F | 1306 | ||
G | 1307 | ||
H | 1309 | ||
I | 1313 | ||
J | 1314 | ||
K | 1315 | ||
L | 1315 | ||
M | 1317 | ||
N | 1320 | ||
O | 1323 | ||
P | 1325 | ||
Q | 1330 | ||
R | 1330 | ||
S | 1333 | ||
T | 1336 | ||
U | 1339 | ||
V | 1339 | ||
W | 1341 | ||
X | 1342 | ||
Y | 1342 | ||
Z | 1342 | ||
End sheets | 1347 | ||
Formulas | 1347 | ||
Surface area rule: | 1347 | ||
Calculating strength of a solution: | 1347 | ||
Calculating flow rate for IV: | 1347 | ||
Calculation of medication dosages: | 1347 | ||
Formula method: | 1347 | ||
Ratio–proportion method: | 1347 | ||
Dimensional analysis method: | 1347 | ||
Temperature conversion: | 1347 | ||
Nomogram for calculation of body surface area | 1348 | ||
Antitoxins and antivenins | es1 | ||
Abbreviations | es2 |